NTRA.NASDAQNatera, INC

Form 4: Natera Co-Founder Jonathan Sheena Sells Shares Under 10b5-1 Trading Plans

Sentiment:

SEC Form 4


Jonathan Sheena, co-founder of Natera, Inc., sold shares of common stock on May 9 and May 12, 2025, under pre-arranged Rule 10b5-1 trading plans.

Summary

  • Jonathan Sheena, a co-founder of Natera, Inc., reported the sale of common stock on May 9 and May 12, 2025.
  • The sales were executed under Rule 10b5-1 trading plans adopted on December 11, 2024, and June 7, 2024.
  • On May 9, 2025, Sheena sold a total of 3,360 shares at prices ranging from $153.95 to $164.03.
  • On May 12, 2025, Sheena sold shares held by Caraluna 1 Trust and Caraluna 2 Trust, totaling 3,300 shares, at prices ranging from $156.53 to $159.77.
  • Following these transactions, Sheena directly owns 251,844 shares of common stock and indirectly owns 38,782 shares through Caraluna 1 Trust and 38,782 shares through Caraluna 2 Trust.

Sentiment

Score: 5

Explanation: The document simply reports stock sales by an insider under a pre-existing trading plan. It doesn't inherently convey positive or negative sentiment about the company's prospects.

Industry Context

Sales by company insiders are a common occurrence and are often pre-planned through Rule 10b5-1 trading plans to avoid accusations of insider trading. The market typically views these sales in the context of the overall health and prospects of the company.

Comparison to Industry Standards

  • It's common for executives at publicly traded companies, such as Natera, to utilize 10b5-1 trading plans to sell shares over time.
  • Comparable companies like Exact Sciences or Invitae also see insider selling activity, often managed through similar pre-arranged plans.
  • The volume and frequency of these sales are generally compared against historical insider trading patterns and industry benchmarks to assess their significance.

Stakeholder Impact

  • The stock sales could have a minor negative impact on shareholder sentiment if investors interpret it as a lack of confidence by the co-founder, although the existence of a 10b5-1 plan mitigates this concern.
  • The sales do not directly impact employees, customers, suppliers, or creditors.

Key Dates

DateDescription
2024-06-07Date of adoption of Rule 10b5-1 trading plan
2024-12-11Date of adoption of Rule 10b5-1 trading plan
2025-05-09Date of stock sale
2025-05-12Date of stock sale
2025-05-13Date of filing

Keywords

Natera, NTRA, Jonathan Sheena, Form 4, Beneficial Ownership, Rule 10b5-1, Stock Sale, Caraluna Trust

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.